Home › Funds › Palo Alto Investors LP › MIRM

Palo Alto Investors LP position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

Palo Alto Investors LP reported holding 387,314 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$33.1M, representing 4.93% of its reported portfolio and ranking #6 among its reported holdings. Palo Alto Investors LP has disclosed MIRM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)387.31K sh
Reported value held$33.11M
Portfolio Weight4.93%
First reportedQ3 2023
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Palo Alto Investors LP's MIRM position evolved

Palo Alto Investors LP first disclosed a stake in MIRM in Q3 2023 at 64,700 shares (US$2.0M). The position peaked in Q2 2026 at 348,808 shares, worth US$40.8M. Across 13 filings, Palo Alto Investors LP increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 387,314 shares valued at US$33.1M — an increase of 38,506 shares quarter over quarter.. Notable position changes include a 142% increase in Q4 2025 (shares rose 17% over the following quarter), a 108% increase in Q1 2026 (shares rose 27% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 64.70K $2.04M New
Q4 2023 64.70K $1.91M Hold
Q1 2024 64.70K $1.63M Hold
Q2 2024 64.70K $2.21M Hold
Q3 2024 64.70K $2.52M Hold
Q4 2024 64.70K $2.68M Hold
Q1 2025 64.70K $2.91M Hold
Q2 2025 64.70K $3.29M Hold
Q3 2025 64.70K $4.74M Hold
Q4 2025 156.42K $12.36M Add
Q1 2026 325.18K $30.04M Add
Q2 2026 348.81K $40.83M Add
Q3 2026 387.31K $33.11M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 39 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$656.5M), EVENTIDE ASSET MANAGEMENT, LLC (US$106.7M), TANG CAPITAL MANAGEMENT LLC (US$105.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has Palo Alto Investors LP held MIRM?

Palo Alto Investors LP has disclosed MIRM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Palo Alto Investors LP's current position in MIRM?

As of Q3 2026, Palo Alto Investors LP holds 387.31K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $33.11M, representing 4.93% of its reported portfolio and ranking #6.

Has Palo Alto Investors LP been buying or selling MIRM?

In the latest 13F filing (Q3 2026), Palo Alto Investors LP increased its position in MIRM. The position peaked in Q2 2026 at 348.81K shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.